Cargando…
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
Activation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutop...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038067/ https://www.ncbi.nlm.nih.gov/pubmed/33800594 http://dx.doi.org/10.3390/ijms22073492 |
_version_ | 1783677289591996416 |
---|---|
author | Brunty, Sarah Ray Wright, Kristeena Mitchell, Brenda Santanam, Nalini |
author_facet | Brunty, Sarah Ray Wright, Kristeena Mitchell, Brenda Santanam, Nalini |
author_sort | Brunty, Sarah |
collection | PubMed |
description | Activation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutopic and ectopic tissues, as well as peritoneal fluid (PF) from IRB-approved and consented patients with and without endometriosis, the expression of PRC2 complex components, JARID2, miR-155 (known regulators of EZH2), and a key inflammatory modulator, FOXP3, was measured. A higher expression of EZH2, H3K27me3, JARID2, and FOXP3 as well as miR-155 was noted in both the patient tissues and in endometrial PF treated cells. Gain-or-loss of function of miR-155 showed an effect on the PRC2 complex but had little effect on JARID2 expression, suggesting alternate pathways. Chromatin immunoprecipitation followed by qPCR showed differential expression of PRC2 complex proteins and its associated binding partners in JARID2 vs. EZH2 pull down assays. In particular, endometriotic PF treatment increased the expression of PHF19 (p = 0.0474), a gene silencer and co-factor that promotes PRC2 interaction with its targets. Thus, these studies have identified the potential novel crosstalk between miR-155-PRC2 complex-JARID2 and PHF19 in endometriosis, providing an opportunity to test other epigenetic targets in endometriosis. |
format | Online Article Text |
id | pubmed-8038067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80380672021-04-12 Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis Brunty, Sarah Ray Wright, Kristeena Mitchell, Brenda Santanam, Nalini Int J Mol Sci Article Activation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutopic and ectopic tissues, as well as peritoneal fluid (PF) from IRB-approved and consented patients with and without endometriosis, the expression of PRC2 complex components, JARID2, miR-155 (known regulators of EZH2), and a key inflammatory modulator, FOXP3, was measured. A higher expression of EZH2, H3K27me3, JARID2, and FOXP3 as well as miR-155 was noted in both the patient tissues and in endometrial PF treated cells. Gain-or-loss of function of miR-155 showed an effect on the PRC2 complex but had little effect on JARID2 expression, suggesting alternate pathways. Chromatin immunoprecipitation followed by qPCR showed differential expression of PRC2 complex proteins and its associated binding partners in JARID2 vs. EZH2 pull down assays. In particular, endometriotic PF treatment increased the expression of PHF19 (p = 0.0474), a gene silencer and co-factor that promotes PRC2 interaction with its targets. Thus, these studies have identified the potential novel crosstalk between miR-155-PRC2 complex-JARID2 and PHF19 in endometriosis, providing an opportunity to test other epigenetic targets in endometriosis. MDPI 2021-03-28 /pmc/articles/PMC8038067/ /pubmed/33800594 http://dx.doi.org/10.3390/ijms22073492 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Brunty, Sarah Ray Wright, Kristeena Mitchell, Brenda Santanam, Nalini Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title_full | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title_fullStr | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title_full_unstemmed | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title_short | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis |
title_sort | peritoneal modulators of ezh2-mir-155 cross-talk in endometriosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038067/ https://www.ncbi.nlm.nih.gov/pubmed/33800594 http://dx.doi.org/10.3390/ijms22073492 |
work_keys_str_mv | AT bruntysarah peritonealmodulatorsofezh2mir155crosstalkinendometriosis AT raywrightkristeena peritonealmodulatorsofezh2mir155crosstalkinendometriosis AT mitchellbrenda peritonealmodulatorsofezh2mir155crosstalkinendometriosis AT santanamnalini peritonealmodulatorsofezh2mir155crosstalkinendometriosis |